Literature DB >> 26678601

Targeting the Hippo pathway: Clinical implications and therapeutics.

Shuai Ye1, T S Karin Eisinger-Mathason2.   

Abstract

The Hippo pathway plays a critical role in tissue and organ size regulation by restraining cell proliferation and apoptosis under homeostatic conditions. Deregulation of this pathway can promote tumorigenesis in multiple malignant human tumor types, including sarcoma, breast, lung and liver cancers. In this review, we summarize the current understanding of Hippo pathway function, it's role in human cancer, and address the potential of Hippo pathway member proteins as therapeutic targets for a variety of tumors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Hippo; YAP

Mesh:

Substances:

Year:  2015        PMID: 26678601     DOI: 10.1016/j.phrs.2015.11.025

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  19 in total

1.  TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).

Authors:  Shuai Ye; Ying Liu; Ashley M Fuller; Rohan Katti; Gabrielle E Ciotti; Susan Chor; Md Zahidul Alam; Samir Devalaraja; Kristin Lorent; Kristy Weber; Malay Haldar; Michael A Pack; T S Karin Eisinger-Mathason
Journal:  Mol Cancer Res       Date:  2020-01-27       Impact factor: 5.852

2.  A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells.

Authors:  Zeming Liu; Wen Zeng; Shi Wang; Xiangwang Zhao; Yawen Guo; Pan Yu; Xingjie Yin; Chunping Liu; Tao Huang
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.

Authors:  Shuai Ye; Matthew A Lawlor; Adrian Rivera-Reyes; Shaun Egolf; Susan Chor; Koreana Pak; Gabrielle E Ciotti; Avery C Lee; Gloria E Marino; Jennifer Shah; David Niedzwicki; Kristy Weber; Paul M C Park; Md Zahidul Alam; Alison Grazioli; Malay Haldar; Mousheng Xu; Jennifer A Perry; Jun Qi; T S Karin Eisinger-Mathason
Journal:  Cancer Res       Date:  2018-02-28       Impact factor: 12.701

4.  Proteomic changes of CD4+/CD25+/forkhead box p3+ regulatory T cells in a 30-day rat model of sepsis survival.

Authors:  Yuxia Jiao; Siqi Tan; Junyu Xiong
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

Review 5.  The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review.

Authors:  Anastasios Kyriazoglou; Michalis Liontos; Roubini Zakopoulou; Maria Kaparelou; Anna Tsiara; Alkistis Maria Papatheodoridi; Rebecca Georgakopoulou; Flora Zagouri
Journal:  Breast Care (Basel)       Date:  2020-05-12       Impact factor: 2.860

6.  RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer Cells.

Authors:  Soo Mi Kim; Shuai Ye; So-Young Rah; Byung Hyun Park; Hongen Wang; Jung-Ryul Kim; Seung Ho Kim; Kyu Yun Jang; Kwang-Bok Lee
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 7.  The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair.

Authors:  Emma Fallahi; Niamh A O'Driscoll; David Matallanas
Journal:  Genes (Basel)       Date:  2016-06-17       Impact factor: 4.096

Review 8.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

9.  Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.

Authors:  Yannick Mesrouze; Fedir Bokhovchuk; Marco Meyerhofer; Patrizia Fontana; Catherine Zimmermann; Typhaine Martin; Clara Delaunay; Dirk Erdmann; Tobias Schmelzle; Patrick Chène
Journal:  Elife       Date:  2017-04-21       Impact factor: 8.140

Review 10.  YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Authors:  Janine S A Warren; Yuxuan Xiao; John M Lamar
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.